Table 3. The baseline characteristics of all type 2 diabetes patients with various genotypes for the PPAR-γ2 rs1801282 and PTPRD rs17584499 polymorphisms before the administration of pioglitazone (n=67).

Parameters	PPAR-γ2 rs1801282			PTPRD rs17584499
	CC	CG	P	CC	CT+TT	P
No (male/female)	60 (35/25)	7 (4/3)	0.952Δ	45 (24/21)	22 (15/7)	0.247Δ
Age (year)	56.77±8.34	55.43±10.41	0.704†	55.62±7.98	58.68±9.33	0.100†
Duration (month)	41.67±35.22	67.71±63.57	0.367†	42.16±39.34	48.96±39.58	0.389†
BMI	25.29±2.79	23.91±2.39	0.213#	25.18±2.59	25.07±3.17	0.713†
FPG (mmol/L)	8.25±1.18	9.16±1.12	0.056#	8.36±1.28	8.30±1.05	0.989†
PPG (mmol/L)	13.17±3.30	12.94±2.89	1.000†	13.48±3.24	12.46±3.20	0.225#
HbA1c (%)	7.49±1.26	8.03±1.78	0.492†	7.65±1.29	7.34±1.36	0.216†
TC (mmol/L)	4.99±0.92	5.23±1.08	0.608†	5.09±0.98	4.86±0.82	0.530†
TG (mmol/L)	1.96±1.14	2.40±1.17	0.223†	2.06±1.22	1.88±0.97	0.694†
HDL-c (mmol/L)	1.10±0.32	1.24±0.29	0.223†	1.13±0.36	1.09±0.19	0.298†
LDL-c (mmol/L)	3.02±0.82	3.18±0.89	0.697†	3.06±0.90	2.98±0.64	0.841†

BMI, body mass index; FPG, fasting plasma glucose; PPG, postprandial plasma glucose; HbA1c, glycated hemoglobin; TC, total cholesterol; TG, triglyceride; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol.

^ΔP values are determined by Pearson χ² test.

^#P values are assessed by two-sample t-test.

^†P values are determined by Mann-Whitney test.